| Product NDC: | 0085-0942 |
| Proprietary Name: | CELESTONE |
| Non Proprietary Name: | Betamethasone |
| Active Ingredient(s): | .6 mg/5mL & nbsp; Betamethasone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0085-0942 |
| Labeler Name: | Schering Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA014215 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110818 |
| Package NDC: | 0085-0942-05 |
| Package Description: | 1 BOTTLE in 1 CARTON (0085-0942-05) > 118 mL in 1 BOTTLE |
| NDC Code | 0085-0942-05 |
| Proprietary Name | CELESTONE |
| Package Description | 1 BOTTLE in 1 CARTON (0085-0942-05) > 118 mL in 1 BOTTLE |
| Product NDC | 0085-0942 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Betamethasone |
| Dosage Form Name | SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 20110818 |
| Marketing Category Name | NDA |
| Labeler Name | Schering Corporation |
| Substance Name | BETAMETHASONE |
| Strength Number | .6 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |